CTXR · Citius Pharmaceuticals, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“The accompanying unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We incurred a net loss of $37,503,635 for the six months ended March 31, 2026. The Company experienced negative cash flows from operations of $14,308,843 for the six months ended March 31, 2026. At March 31, 2026, the Company had $4,590,174 in cash and a negative working capital of approximately $23.3 million.”View the 10-Q filed May 15, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2025-08-08 | Mazur Leonard L |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
125,490 |
| 2025-08-08 | HOLUBIAK MYRON Z |
Director, Secretary |
Other↓
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
31,373 |
| 2025-08-08 | HOLUBIAK MYRON Z |
Director, Secretary |
Other↓
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
22,344 |
| 2025-08-08 | Mazur Leonard L |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
89,388 |
| 2025-08-08 | HOLUBIAK MYRON Z |
Director, Secretary |
Award↑
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
31,373 |
| 2025-08-08 | Mazur Leonard L |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
125,490 |
| 2025-08-08 | Mazur Leonard L |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
89,388 |
| 2025-08-08 | HOLUBIAK MYRON Z |
Director, Secretary |
Award↑
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares. The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
22,344 |
| 2024-11-07 | Dutia Suren G |
Director |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Stock Option (Right to Purchase Common Stock)
|
125,000 |
| 2024-11-07 | Czuczman Myron |
Chief Medical Officer |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. |
Stock Option (Right to Purchase Common Stock)
|
300,000 |
| 2024-11-07 | Smith Robert Joseph |
Director |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Stock Option (Right to Purchase Common Stock)
|
125,000 |
| 2024-11-07 | HOLUBIAK MYRON Z |
Director, Secretary |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. |
Stock Option (Right to Purchase Common Stock)
|
350,000 |
| 2024-11-07 | Mazur Leonard L |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on November 7, 2024. The options vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. |
Stock Option (Right to Purchase Common Stock)
|
600,000 |
| 2024-11-07 | HOLUBIAK MYRON Z |
Director, Secretary |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Indirect)
The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares. |
Stock Option (Right to Buy)
(I)
|
75,000 |
| 2024-11-07 | Webb Carol |
Director |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Stock Option (Right to Purchase Common Stock)
|
125,000 |
| 2024-11-07 | Bartushak Jaime |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date |
Stock Option (Right to Purchase Common Stock)
|
350,000 |
| 2024-11-07 | Holuka Eugene Myron |
Director |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Stock Option (Right to Purchase Common Stock)
|
125,000 |
| 2024-11-07 | MCGRATH DENNIS M |
President and CFO |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Stock Option (Right to Purchase Common Stock)
|
125,000 |
| 2024-09-25 | Mazur Leonard L |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
2,234,700 |
| 2024-09-25 | HOLUBIAK MYRON Z |
Director, Secretary |
Other↓
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
558,597 |
| 2024-09-25 | Mazur Leonard L |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
2,234,700 |
| 2024-09-25 | HOLUBIAK MYRON Z |
Director, Secretary |
Award↑
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
558,597 |
| 2024-08-14 | Mazur Leonard L |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
3,137,255 |
| 2024-08-14 | Mazur Leonard L |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
3,137,255 |
| 2024-08-14 | HOLUBIAK MYRON Z |
Director, Secretary |
Award↑
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
784,314 |
| 2024-08-14 | HOLUBIAK MYRON Z |
Director, Secretary |
Other↓
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
784,314 |
| 2024-04-03 | HOLUBIAK MYRON Z |
Director, Secretary |
Other↓
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
129,450 |
| 2024-04-03 | Mazur Leonard L |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
1,165,048 |
| 2024-04-03 | HOLUBIAK MYRON Z |
Director, Secretary |
Award↑
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
129,450 |
| 2024-04-03 | Mazur Leonard L |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Warrant to Purchase Common Stock (Direct)
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. |
Warrant to Purchase Common Stock
|
1,165,048 |
| 2024-03-14 | Smith Robert Joseph |
Director |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on March 14, 2024, with a Vesting Commencement Date of March 12, 2024, the date of the Optionee's election to the Board of the Company. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Stock Option (Right to Purchase Common Stock)
|
75,000 |
| 2024-03-13 | Holuka Eugene Myron |
Director |
Convert↓
|
Stock Option (Right to Purchase Common Stock)
|
2,415 |
| 2024-03-13 | Holuka Eugene Myron |
Director |
Tax↓
|
Common Stock
|
48 |
| 2024-03-13 | Holuka Eugene Myron |
Director |
Convert↑
|
Common Stock
|
2,415 |
| 2024-03-12 | Smith Robert Joseph |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2024-03-04 | Webb Carol |
Director |
Convert↓
|
Stock Option (Right to Purchase Common Stock)
|
12,071 |
| 2024-03-04 | Webb Carol |
Director |
Tax↓
|
Common Stock
|
236 |
| 2024-03-04 | Webb Carol |
Director |
Convert↑
|
Common Stock
|
12,071 |
| 2023-10-10 | MCGRATH DENNIS M |
President and CFO |
Award↑
Filing footnotes — Options to Purchase Common Stock (Direct)
The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Options to Purchase Common Stock
|
75,000 |
| 2023-10-10 | Webb Carol |
Director |
Award↑
Filing footnotes — Options to Purchase Common Stock (Direct)
The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Options to Purchase Common Stock
|
75,000 |
| 2023-10-10 | HOLUBIAK MYRON Z |
Director, Secretary |
Award↑
Filing footnotes — Options to Purchase Common Stock (Direct)
The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. |
Options to Purchase Common Stock
|
400,000 |
| 2023-10-10 | Czuczman Myron |
Chief Medical Officer |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. |
Stock Option (Right to Purchase Common Stock)
|
300,000 |
| 2023-10-10 | Mazur Leonard L |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Option to Purchase Common Stock (Direct)
The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. |
Option to Purchase Common Stock
|
550,000 |
| 2023-10-10 | Bartushak Jaime |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Purchase Common Stock) (Direct)
The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date. |
Stock Option (Right to Purchase Common Stock)
|
300,000 |
| 2023-10-10 | Dutia Suren G |
Director |
Award↑
Filing footnotes — Options to Purchase Common Stock (Direct)
The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Options to Purchase Common Stock
|
75,000 |
| 2023-10-10 | Holuka Eugene Myron |
Director |
Award↑
Filing footnotes — Options to Purchase Common Stock (Direct)
The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Options to Purchase Common Stock
|
75,000 |
| 2023-02-07 | MCGRATH DENNIS M |
President and CFO |
Other↑
|
No Securities Owned
|
0 |
| 2023-02-07 | MCGRATH DENNIS M |
President and CFO |
Award↑
Filing footnotes — Options to Purchase Common Stock (Direct)
The options were granted on February 7, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Options to Purchase Common Stock
|
75,000 |
| 2022-10-04 | Webb Carol |
Director |
Award↑
Filing footnotes — Options to Purchase Common Stock (Direct)
The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Options to Purchase Common Stock
|
75,000 |
| 2022-10-04 | SAFIR HOWARD |
Director |
Award↑
Filing footnotes — Options to Purchase Common Stock (Direct)
The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
Options to Purchase Common Stock
|
75,000 |